Close Menu

NEW YORK (GenomeWeb) – Several Bionano Genomics customers have recently been testing the firm's Saphyr optical genome mapping platform for clinical applications in hematologic cancer and inherited disease, comparing it against standard cytogenetic diagnostic assays. In the meantime, the San Diego-based company has been working on updates that will become available later this year to increase the system's throughput and streamline its sample prep workflow.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.